LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 30.85
-0.25 (-0.80%)
Feb 11, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 2.49 billion as of February 13, 2026. Its market cap has increased by 46.90% in one year.
Market Cap
2.49B
Enterprise Value
2.16B
Revenue
118.93M
Ranking
n/a
PE Ratio
49.73
Stock Price
30.85
Market Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 2.49B, an increase of 44.38%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.49B | -4.93% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient EuroPharma | 3.83B |
| Merdury Biopharmaceutical | 3.58B |
| Maywufa Company | 2.92B |
| PhytoHealth | 2.89B |
| Golden Biotechnology | 2.71B |
| Johnson Chemical Pharmaceutical Works | 2.55B |
| Allied Biotech | 2.35B |
| TSH Biopharm Corporation | 2.15B |